ReviewInternational journal of molecular medicine2026
Unveiling the role of spatial transcriptomics in the analysis of the tumor immune microenvironment (Review).
Review in International journal of molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The tumor immune microenvironment plays a decisive role in tumor initiation, progression and therapeutic response. Spatial transcriptomics (ST) enables comprehensive analysis of the whole transcriptome or specific gene sets while preserving the original spatial location information within tissues, offering a revolutionary approach to unraveling the complexity of the tumor immune microenvironment in the spatial dimension. The present review aims to systematically elaborate on the role and application of ST in deciphering the tumor immune microenvironment. Focusing on tumor microenvironment niches at different stages of tumor progression, from precancerous lesions and locally advanced tumors to distant metastasis, recent advances in ST for mapping the spatial distribution and functional states of key cell subpopulations are summarized. The present review further highlights its potential for clinical translation in identifying spatially defined biomarkers and elucidating the mechanisms underlying therapeutic responses and analyze the key technical challenges that constrain the application of ST in clinical practice. In recent years, the rapid development of machine learning algorithms has provided new opportunities to overcome the technical limitations of ST. The deep integration of machine learning with ST is laying a solid theoretical foundation and technical support for precision medicine and early intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.